+95-1-3592223, +95-1-3592224, +95-1-3592124, +95-1-3592125 (Ext. 320, 245)
contact.pmi@pacific-aa.com
logo-img logo-img
  • Home
  • Products
  • Factory
  • About Us
    • Introduction
    • Managing Director's Message
    • Vision & Mission
    • Milestones
    • Certificate
    • News and Media
    • CSR
  • Contact
logo-img
Admin Dec 30, 2020

Myanmar’s first ever locally manufactured drug for Covid-19 Pandemic: “FAVIPAC (Favipiravir 200mg), COVID-19 treatment (oral tablets)

To produce Favipiravir 200mg (Original Product’s Brand Name: Avigan from Japan), a product used by countries like &Japan, Russia, China, India, Taiwan, countries in Europe and South America, PMI’s foreign research & formulation scientists along with local pharmacists have collaborated to produce this Covid-19 treatment as generic medicine using imported raw materials at PMI’s R & D Center.

Read More!

Popular Tags

csr manufacturing covid-19 news myanmar aa pmi
Address

209/210/211, Corner of Kannar St. & Khun Act Thar Minthar St., City of Industry, Dagon Seikkan Township, Yangon Myanmar.

Call Us On

+95-1-3592223, +95-1-3592224, +95-1-3592124, +95-1-3592125 (Ext. 320, 245)

Email Us

contact.pmi@pacific-aa.com

On July 23, 2017, we celebrated the official opening of Pacific Medical Industries Ltd (PMI) new US $20 million manufacturing facility in Yangon, a symbol of progress for the entire nation.

Read More!

Useful Links

  • About Us
  • Contact Us
  • News Room
  • CSR
  • Products
  • Milestone

Recent Posts

  • Myanmar’s first ever locally manufactured drug for Covid-19 Pandemic: “FAVIPAC (Favipiravir 200mg), COVID-19 treatment (oral tablets) Jan 25, 2021 Myanmar’s first ever locally manufactured drug for...
  • Pacific Alpine Myanmar (a member of Pacific-AA Group) received "2019 AMCHAM CSR Excellence (ACE) Award" Dec 26, 2020 Pacific Alpine Myanmar (a member of Pacific-AA Gro...
Copyright © 2025 PMI. Powered by Mega Myanmar Link